CASE REPORT
Published on 03 Jan 2024
Neoadjuvant chemoimmunotherapy achieved a pathologic complete response in stage IIIA lung adenocarcinoma harboring RET fusion: a case report
doi 10.3389/fimmu.2023.1258762
- 880 views
- Frontiers in Oncology
- Thoracic Oncology
- Research Topics
- Neoadjuvant Therapy in Non-Small Cell Lung Cancer: Clinical, Pathological and Translational Research - Volume II
Neoadjuvant Therapy in Non-Small Cell Lung Cancer: Clinical, Pathological and Translational Research - Volume II
5,416
Total downloads
18k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
REVIEW
Published on 08 Dec 2023
Neoadjuvant therapy in non-small cell lung cancer: basis, promise, and challenges
doi 10.3389/fonc.2023.1286104
- 3,854 views
- 4 citations
BRIEF RESEARCH REPORT
Published on 19 Sep 2023
ctDNA-based detection of molecular residual disease in stage I-III non-small cell lung cancer patients treated with definitive radiotherapy
doi 10.3389/fonc.2023.1253629
- 4,269 views
- 6 citations
CASE REPORT
Published on 18 May 2023
Case Report: Complete pathologic response to neoadjuvant selpercatinib in a patient with resectable early-stage RET fusion-positive non-small cell lung cancer
doi 10.3389/fonc.2023.1178313
- 2,310 views
- 4 citations
STUDY PROTOCOL
Published on 09 Mar 2023
Therapeutic drug monitoring guided dosing versus standard dosing of alectinib in advanced ALK positive non-small cell lung cancer patients: Study protocol for an international, multicenter phase IV randomized controlled trial (ADAPT ALEC)
doi 10.3389/fonc.2023.1136221
- 5,249 views
- 4 citations
Published in
Frontiers in Oncology
- Thoracic Oncology
Impact
- 18kTopic views
- 12kArticle views
- 5,416Article downloads